Company
A2 Biotherapeutics
| Industry | clinical-stage cell therapy company developing logic-gated cell therapies to selectively target tumor cells and protect normal cells |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| A2 Biotherapeutics | Series C | 2025-01-09 |
Company
| Industry | clinical-stage cell therapy company developing logic-gated cell therapies to selectively target tumor cells and protect normal cells |
|---|
| Company | Round | Date |
|---|---|---|
| A2 Biotherapeutics | Series C | 2025-01-09 |